Subscribe: Clinical Trials / Drug Trials News From Medical News Today
Added By: Feedage Forager Feedage Grade A rated
Language: English
alzheimer  clinical trials  clinical  new study  new  patients  phase  research  results  study  treatment  trial  trials  vaccine 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Clinical Trials / Drug Trials News From Medical News Today

Clinical Trials / Drug Trials News From Medical News Today

Clinical trials are a type of research study to explore whether a medical treatment, drug, strategy or device is safe and effective for human use. The purpose of clinical trials is research, so the studies follow strict scientific standards. These standar

Copyright: Copyright 2016 Medical News Today

Expectations may not match reality among cancer patients in some early phase clinical trials

Mon, 26 Sep 2016 00:00:00 PDT

In a study of cancer patients considering whether they should participate in phase I clinical trials, a high percentage were willing to participate after discussions with clinical staff, but nearly...

Sugar and heart disease: The sour side of industry-funded research

Wed, 21 Sep 2016 08:00:00 PDT

We investigate the discovery of an influential 1960s study that was funded by the sugar industry to play down the link between sugar and heart disease.

Under-reporting of side effects in clinical research

Tue, 20 Sep 2016 11:00:00 PDT

Side effects are incompletely reported in peer-reviewed journal articles describing research findings on the clinical benefits of drugs and other medical treatments, according to a systematic...

Positive data presented demonstrating erenumab significantly reduces monthly migraine days in patients with chronic migraine

Tue, 20 Sep 2016 00:00:00 PDT

Amgen has announced detailed global Phase 2 results showing erenumab demonstrated a statistically significant reduction in monthly migraine days compared with placebo in patients with chronic...

Statins: 'Harms have been overestimated,' says review

Fri, 09 Sep 2016 07:00:00 PDT

An in-depth review into the health outcomes of statin therapy suggests the benefits of the cholesterol-lowering drugs outweigh the risks.

New research method questions traditional efficacy trial model

Tue, 06 Sep 2016 00:00:00 PDT

Traditional efficacy trials have limited relevance to everyday clinical practice and should be changed, according the authors of a new study into chronic obstructive pulmonary disease (COPD)...

Asthma flare-ups reduced by antibody injection

Tue, 06 Sep 2016 00:00:00 PDT

Two trials have found that giving benralizumab injections over the course of a year may reduce the frequency of asthma exacerbations in severe asthma.

Pioneering Alzheimer's prevention study starts enrolling high-risk older adults

Fri, 26 Aug 2016 05:00:00 PDT

Researchers study whether two new drugs can reduce or eliminate protein linked to Alzheimer's.

Marijuana a better pain reliever for men than women

Fri, 19 Aug 2016 07:00:00 PDT

Compared with men who smoked marijuana, women did not experience a significant reduction in pain sensitivity, a new study reveals.

Outsourcing in Clinical Trials East Asia, Nov 30th - 1st Dec 2016, Seoul

Thu, 18 Aug 2016 05:00:00 PDT

Arena International is proud to launch the newest event to the Outsourcing in Clinical Trials series; OCT East Asia.

Could memory loss be reversed with a common painkiller?

Thu, 11 Aug 2016 07:00:00 PDT

Researchers reveal a common NSAID called mefenamic acid reversed memory loss in mouse models of Alzheimer's disease, paving the way for human trials.

Sex hormones skew outcomes in clinical trials - here's how

Wed, 10 Aug 2016 07:00:00 PDT

Clinical research often excludes females from their trials under the assumption that "one size fits all," that a painkiller or antidepressant will be equally effective in subjects of either sex...

New asthma pill reduces troublesome symptoms

Mon, 08 Aug 2016 07:00:00 PDT

In what is hailed as a 'game changer' for future asthma treatment, a new study shows an asthma pill is effective in treating symptoms of the condition.

Phase 3 results for Cx601 in treatment of complex perianal fistulas in patients with Crohn's disease

Mon, 08 Aug 2016 05:00:00 PDT

Takeda Pharmaceutical Company Limited and TiGenix NV have announced that the 24-week results of the Phase 3 ADMIRE-CD trial investigating Cx601 have been published in The Lancet.

Zika vaccine offers complete protection in monkeys

Fri, 05 Aug 2016 00:00:00 PDT

A Zika vaccine called ZPIV has shown complete protection in both mice and monkeys, and it is now due to enter human trials later this year.

Clinical trial results support adalimumab treatment for painful skin condition

Fri, 05 Aug 2016 00:00:00 PDT

The results of two phase 3 clinical trials that led to FDA approval of adalimumab for treatment of the chronic inflammatory skin disease hidradenitis suppurtiva (HS) are being published in the New...

NIH begins testing investigational Zika vaccine in humans

Thu, 04 Aug 2016 09:00:00 PDT

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a clinical trial of a vaccine candidate intended to prevent Zika virus...

Alzheimer's drug shows promise for patients in phase III trial

Fri, 29 Jul 2016 00:00:00 PDT

Researchers complete the first ever phase III trial of a drug that reduces formation of tau 'tangles' in the brain, offering hope to Alzheimer's patients.

NIH launches early-stage yellow fever vaccine trial

Thu, 28 Jul 2016 09:00:00 PDT

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun an early-stage clinical trial of an investigational vaccine designed to...

ALS Ice Bucket Challenge fuels novel gene discovery

Thu, 28 Jul 2016 08:00:00 PDT

Thanks to donations from 2014's ALS Ice Bucket Challenge, researchers reveal they have discovered a new gene that contributes to ALS development.

Neurovance announces positive centanafadine Phase 2b results for adult ADHD, and plans for Phase 3 trials

Thu, 28 Jul 2016 07:00:00 PDT

Neurovance, Inc. has announced that its Phase 2b trial of centanafadine SR (CTN), a non-stimulant for the treatment of adults with ADHD, met both the primary and secondary endpoints.

Resveratrol study offers new insight into Alzheimer's

Thu, 28 Jul 2016 00:00:00 PDT

Resveratrol - a chemical found in certain plant-based foods - helps researchers understand more about the damaging immune response in Alzheimer's brains.

New study to help people withdraw from inappropriate long-term antidepressant treatment

Wed, 27 Jul 2016 00:00:00 PDT

One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.

Alzheimer's vaccine steps closer with new study

Mon, 18 Jul 2016 08:00:00 PDT

A new vaccine combination has proven successful in mouse models of Alzheimer's, new study reveals, and it could be tested in humans within 3-5 years.

Moffitt Cancer Center launches nationwide e-cigarette study

Wed, 13 Jul 2016 05:00:00 PDT

The research study seeks 2,500 adult smokers who use both cigarettes and e-cigarettes.The use of electronic cigarettes ("e-cigarettes") has increased dramatically in recent years.